Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors

Objective: chronic myeloid leukemia (CML) is a myeloproliferative confusion characterized by the occurrence of an acquired mutation which affect the hematopoietic stem cell, treatment of CML with tyrosine kinase inhibitors (TKI) has resulted in high response rates compared to the interferon alpha a...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah Hasan Al kaabi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	College of Pharmacy / Mustansiriyah University 2018-03-01
Serie:	Al-Mustansiriyah Journal of Pharmaceutical Sciences
Soggetti:	chronic myeloid leukemia serum calcium and phosphatelevels tyrosin kinase inhibitors
Accesso online:	https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/77
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!